Category: Pharma News

IBRUNAT : NATCO NEWLY LAUNCHED DRUG UNDER IBRUTINIB 140MG CAPSULES | IMBRUVICA GENERIC

We at MedsDots.Net True Indian Pharmacy is pleased to announce newly launched drug IBRUNAT 140mg Capsules authentically and rightfully manufactured by Natco Pharma Limited (pharmaceutical company located in Hyderabad, India) containing a paragraph IV certification with the U.S. Food and...

Indian Sofosbuvir & Velpatasvir Tablets

Epclusa : New Hepatitis C Drug Treatment Medicine . Gilead Sciences will allow seven large Indian generic drug producers to make and sell its blockbuster hepatitis C drug in more than 90 developing countries, in a move it says will ensure affordable access to the potentially...

Exelixis initiates Phase III trial of cabozantinib to treat (RCC) Renal Cell Carcinoma

Exelixis is commencing a Phase III pivotal trial to evaluate cabozantinib (CABOMETYX) for the treatment of patients with previously untreated advanced renal cell carcinoma (RCC). As part of the trial, cabozantinib will be evaluated in combination with nivolumab (Opdivo) and...

Natco India settles patent dispute with Onyx Therapeutics for blood cancer drug Carfilzomib

Natco has partnered with Breckenridge Pharmaceutical, which will market the product in the US. Indian Drug maker Natco Pharma on May 30th, 2019 said it has reached an out-of-court settlement in the US with Onyx Therapeutics over patent litigation related to the generic...

Novartis New launch Zolgensma, a gene therapy, will cost $2.1 million

Zolgensma from Novartis is the most expensive drug ever Approved via FDA this Friday Novartis The Federal Food and Drug Administration has authorized a gene remedy for a uncommon childhood disease that is now the most costly drug on the...